We are a drug discovery venture for development of “cancer immunotherapy”, and are currently revolutionizing and expanding the frontiers of cancer therapy. We have a pipeline with a wide variety of drug types, from the exploratory drug discovery stage through to late-phase clinical studies, and we are developing these globally.
